Nobuyuki Arakawa, Co-founder, President and CEO of Celaid Therapeutics, will participate as a panelist at the 1st KYOTO KLIS-X MEETUP 2026, to be held on Thursday, August 20, 2026.
The event will bring together speakers from academia and startups in the fields of iPS cells and regenerative medicine for a panel discussion, startup and academic pitches, and roundtable discussions on key industry challenges. It will also provide networking opportunities for investors, companies, entrepreneurs, researchers, and other life science professionals interested in cutting-edge regenerative medicine and its commercialization.
Program
15:00 Registration opens
15:30–15:40 Opening Remarks
15:40–16:10 Panel Discussion
“How Can We Identify Promising Business Opportunities from Infinite Possibilities?”
Panelists
Hidetoshi Masumoto
Specially Appointed Professor to the President, Department of Cardiovascular Surgery, Kansai Medical University; Visiting Researcher, Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University
Nobuyuki Arakawa
Co-founder, President and CEO, Celaid Therapeutics Inc.
Shinya Kasuga
General Partner, IT-Farm (Moderator)
16:10–16:55 Academia & Startup Pitches
16:55–17:45 Thematic Roundtable Discussions (4 groups)
17:45–18:00 Closing Remarks
18:00–19:30 Networking Reception (8F)
Registration
Please register via the event registration form. Non-members who wish to attend are required to register for KLIS-X membership (free of charge).
Contact
Advanced Science, Technology & Management Research Institute of KYOTO (ASTEM)
Kyoto Life Science Innovation Support Center (KLISC), Regional Industry Promotion Division
TEL: 075-950-0880
E-mail: ikouyaku@astem.or.jp